ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
136 hedge funds and large institutions have $537M invested in iTeos Therapeutics in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 50 increasing their positions, 43 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 134 → 136 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
57% less call options, than puts
Call options by funds: $9.69M | Put options by funds: $22.5M
Holders
136
Holding in Top 10
2
Calls
$9.69M
Puts
$22.5M
Top Buyers
| 1 | +$26M | |
| 2 | +$18.6M | |
| 3 | +$17M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.15M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$7.56M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$13.4M | |
| 3 | -$9.52M | |
| 4 |
Morgan Stanley
New York
|
-$8.06M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.99M |